论文部分内容阅读
目的:分析血清甲胎蛋白(AFP)、人附睾蛋白4(HE4)、可溶性间皮素相关肽(SMRP)水平与卵巢癌的相关性。方法:选取2012年1月~2015年1月我院收治的200例卵巢癌患者为研究组,80例健康妇女为对照组,2组妇女均接受血清AFP、HF4及SMRP水平检测,并分析其与卵巢癌的相关性。结果:与对照组相比,卵巢癌患者血清AFP、HE4及SMRP水平显著升高(P<0.05)。结论:血清AFP、HE4及SMRP水平与卵巢癌存在相关性,上述指标可用于卵巢癌的早期诊断及治疗过程中病情的监测与疗效评估,具有较高的临床价值。
Objective: To analyze the correlation between serum alpha-fetoprotein (AFP), human epididymal protein 4 (HE4), soluble mesothelin-related peptide (SMRP) and ovarian cancer. Methods: A total of 200 ovarian cancer patients admitted to our hospital from January 2012 to January 2015 were enrolled in this study. Eighty healthy women were selected as control group. Two groups of women received serum AFP, HF4 and SMRP levels, Correlation with ovarian cancer. Results: Compared with the control group, serum AFP, HE4 and SMRP levels in patients with ovarian cancer were significantly increased (P <0.05). Conclusion: The serum levels of AFP, HE4 and SMRP are correlated with ovarian cancer. The above indexes can be used in the early diagnosis of ovarian cancer and the evaluation of the curative effect in the course of treatment, which has high clinical value.